The Club will be able to access the departments of Toshiba Ultrasound and MRI Engineering
From this season, Toshiba Medical Systems Europe will be an official partner of FC Barcelona in the field of medical services. The European subsidiary of the Toshiba Medical Systems Corporation will supply 13 Ultrasound Systems and one Magnetic Resonance Imaging System to the Club’s medical centre, which will help to improve injury prevention and diagnosis and assist with the rehabilitation of players in the different professional and amateur sections.
As a result of this five-year agreement, the Club will be able to access the departments of Toshiba Ultrasound and MRI Engineering, which supply the very latest technology for diagnostic imagining, and will also provide support and advisory services to the FC Barcelona doctors.
Toshiba Medical Systems Europe (CMSE) is a regional subsidiary of Toshiba Medical Systems Corporation, the world’s leading supplier of diagnostic imaging systems: Ultrasound, Digital Radiology, Interventionist Radiology, Computerised Tomography, Magnetic Resonance, Nuclear Medicine and integral solutions.
Statement by Jordi Monés, director responsible for the FC Barcelona Medical Area:
“We are very satisfied with this deal. Toshiba is a prestigious international brand that is a leader in diagnostic imaging and with a great commitment to scientific investigation. This agreement strengthens our diagnostic capacity with one of the most important global brands in the Medical field and is a further step into Japan where FC Barcelona has an immense supporter base”
Statement by Toshio Takiguchi, President and CEO of Toshiba Medical Systems Corporation:
“We are happy to have our leading global brand partner with one of the best clubs in the world, FC Barcelona. This partnership will strengthen both brands as they continue their passion for sport and the values associated with it. Those values that FCB represents, such as respect, effort, ambition, teamwork and humility, are also relevant in our Company’s culture.”